Solvonis advances PTSD drug program with new compounds
Solvonis Therapeutics PLC has made progress in developing new treatments for post-traumatic stress disorder (PTSD). The London-based company has completed…
Solvonis Therapeutics PLC has made progress in developing new treatments for post-traumatic stress disorder (PTSD). The London-based company has completed…
Рынок лекарств от депрессии, по прогнозам, будет демонстрировать значительный рост в период с 2025 по 2032 год, говорится в новом отчете...